Home
Acute Ischemic Stroke
Unmet Clinical Need
Our Solution
The Team
Our Company
Careers
IN THE NEWS
Contact Us
Product Safety Information
Privacy Policy
Close (Esc)
Unit 6, Galway Business Park, Dangan
Galway,
H91 W7CP,
Ireland
News Signup
Press
IN THE NEWS
News
April 2025
Perfuze CEO Wayne Allen features at SmartTREK
Wayne Allen Discusses the Company, its Novel Technology and Strategies for Growth in the U.S. Market
Read more
April 2025
Pefuze announces two significant milestones...
Completion of Enrollment in Pivotal US Clinical Study & Joe Rotger as Executive VP of Sales
Read more
March 2025
FDA 510(k) Clearance for Perfuze's Zipline™...
Perfuze Receives FDA 510(k) Clearance & Secures €22M in Additional Funding
Read more
December 2023
Millipede 070 Aspiration & 2nd Gen Millipede...
FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment
READ MORE
November 2023
PRESENTED POSTER - SVIN 2023
First-in-Human Experience Using Millipede 088 Aspiration Catheter in Stroke Thrombectomy
Read More
November 2023
MARRS Trial: 1st Patient Enrolled
First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial at StonyBrook
Read More
June 2023
LATE BREAKING ABSTRACT - SNIS 2023
Multi-Center Experience Using the Millipede 088 Superboare Catheter in Stroke Thrombectomy
Read More
June 2023
Perfuze Announces Appointment of New Chair of...
Hooman Hakami Named New Chair of the Board
Read More
February 2023
Millipede 088 Access Catheter
Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter
Read More
March 2022
Neurovascular Company Perfuze Raises €22.5M...
Series A for New Stroke Treatment. Perfuze Raises €22.5M
Read More
prev
1
2
3
next